April 2020: The Nippon Gases Group and its respiratory therapies division Oximesa are firmly committed to assisting in the fight to tackle the coronavirus pandemic. Like so many other liquid oxygen providers, PSA system innovators and medical equipment suppliers, the company was entrenched in the frontline fight again Covid-19.
In terms of sector share, Nippon Gases is one of largest producers of medical oxygen in Europe with production plants and pharmaceutical laboratories, both for production and for filling, with a strong distribution service.
The company had highlighted the essential role that medical oxygen was playing in the fight against Covid-19, urging even back then at what we now consider the early stages of the pandemic, that it was extremely necessary to ensure the supply of not only masks or ventilators, but also of medical oxygen to hospitals, residences and individual homes. This would ultimately go onto become a painful and at times tragic lesson learned during the pandemic.
... to continue reading you must be subscribed
